Skip to main content

Table 3 Multiple logistic regression analysis on anthracycline-induced subclinical cardiotoxicity in DLBCL patients completed 3 cycles chemotherapy

From: Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP

Characteristics OR (95%CI)
(Adjusted)
P-value
Age, per 1 year 1.053 (0.987, 1.124) 0.118
Male, yes versus no 3.212 (0.680, 15.185) 0.141
Smoking, yes versus no 2.601 (0.450, 15.016) 0.285
BMI, per 1 kg/m2 1.239 (0.967, 1.589) 0.090
NT-proBNP, per 1 ng/L 0.995 (0.988, 1.002) 0.179
e’, per 1 cm/s 2.045 (1.201, 3.481) 0.008
TG, per 1 mmol/L 2.810 (1.114, 7.088) 0.029
LDL-C, per 1 mmol/L 0.833 (0.315, 2.200) 0.712
ApoA1, per 1 g/L 0.032 (0.002, 0.611) 0.022
HDL-C, per 1 mmol/L 0.057 (0.003, 0.964) 0.047
  1. Age, gender, and variables with P < 0.10 in Table 2 (smoking history, BMI, NT-proBNP, e’, TG and LDL-C) were considered as potential cofounding factors
  2. Bold values indicate statistical significance (P < 0.05)
  3. ApoA1 Apolipoprotein A1, BMI Body mass index, DLBCL Diffuse large-B cell lymphoma, e’ mitral e’ velocity, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, NT-proBNP N terminal-pro brain natriuretic peptide, TG Total triglyceride, OR Odds ratio